This is to announce that Aisei Holdings Co., Ltd. (“SPC”), a special purpose company established and held by our wholly managed and operated investment fund, J-STAR No. 2 Investment Limited Partnership (“J-STAR No2”), has completed a tender offer toward Aisei Pharmacy Co., Ltd. (headquarters: Chiyoda, Tokyo, company representative: Ms. Emi Fujii, URL: http://www.aisei.co.jp/, JASDAQ 3170, “Aisei”) on March 22, 2016.
In approaching the acquisition, we enlisted ASPASIO Co., Ltd., Nomura Securities Co., Ltd. TMI Associates, PricewaterhouseCoopers Co., Ltd., PwC Tax Japan, KPMG Healthcare Japan Co., Ltd. Also, the SPC will finance capital for settlement of the tender offer from capital injection by financial sponsors including J-STAR No 2 in a form of common shares, from MCo Corporation in a form of Mezzanine, and from Mizuho Bank., Ltd. in a form of bank loan.
For more information, please refer to press release published by Aisei on March 23, 2016 (the press release is only available in Japanese).
# # #